These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4742500)

  • 1. Phase I study of tilorone, a non-marrow depressing antitumor agent.
    Wampler GL; Kuperminc M; Regelson W
    Cancer Chemother Rep; 1973 Apr; 57(2):209-17. PubMed ID: 4742500
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon induction and suppression of solid tumor growth in rats by tilorone hydrochloride.
    Rhoads AR; West WL; Morris HP
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):741-50. PubMed ID: 4356214
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo cytogenetic investigations of tilorone HCl.
    Green S; West WL; McKinstry DW
    Mutat Res; 1974 Oct; 26(5):395-400. PubMed ID: 4413805
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor action of pyran copolymer and tilorone against Lewis lung carcinoma and B-16 melanoma.
    Morahan PS; Munson JA; Baird LG; Kaplan AM; Regelson W
    Cancer Res; 1974 Mar; 34(3):506-11. PubMed ID: 4812258
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of the newly-developed Czechoslovak cytostatic, Benfluron, on the morphology of the blood and bone marrow in laboratory rats].
    Berger J; Nĕmec J
    Cas Lek Cesk; 1986 Aug; 125(31):969-73. PubMed ID: 3731239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative study of the regeneration of bone marrow morphology after administration of high doses of benfluron to laboratory rats].
    Berger J
    Cas Lek Cesk; 1985 Mar; 124(12):371-5. PubMed ID: 4005909
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of Rauscher leukemia virus and avian myeloblastosis virus DNA polymerases by tilorone (NSC-143969) and its analogs.
    Schafer MP; Chirigos MA; Papas TS
    Cancer Chemother Rep; 1974; 58(6):821-27. PubMed ID: 4374997
    [No Abstract]   [Full Text] [Related]  

  • 8. [Organ changes in healthy rabbits following long-term myelobromol treatments].
    Fleischer J; Irmscher J; Morgenstern D; Kemmer C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):259-65. PubMed ID: 4195269
    [No Abstract]   [Full Text] [Related]  

  • 9. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Saito A; Oride M; Munaka M; Uozumi T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of toxic doses of selected antineoplastic drugs on the hematopoietic system of mice after splenectomy].
    Robak T
    Acta Haematol Pol; 1980; 11(3):181-7. PubMed ID: 7445921
    [No Abstract]   [Full Text] [Related]  

  • 11. Complications of cytotoxic antineoplastic chemotherapy.
    White DR; Cooper MR; Muss HB; Richards F; Spurr CL
    N C Med J; 1979 Feb; 40(2):73-8. PubMed ID: 370616
    [No Abstract]   [Full Text] [Related]  

  • 12. Antitumor activity of tilorone hydrochloride on a transplantable rat adenocarcinoma.
    Kellen JA; Mirakian A
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):185-8. PubMed ID: 7291725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study of the effect of rubomycin C and B on peripheral blood of animals].
    Vertogradova TP
    Antibiotiki; 1969 Sep; 14(9):840-5. PubMed ID: 5361829
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy with cytostatic drugs in the elderly].
    Sauer H
    Internist (Berl); 1991 Aug; 32(8):479-85. PubMed ID: 1938269
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I trial of pentamethylmelamine.
    Ajani JA; Cabanillas FF; Bodey GP
    Cancer Treat Rep; 1982 May; 66(5):1227-8. PubMed ID: 6805950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear bodies produced in astrocytes by tilorone.
    Levine S; Sowinski R; Hoenig EM
    Am J Pathol; 1975 Feb; 78(2):319-32. PubMed ID: 163594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an oral interferon-inducer on the hematopoietic and reticuloendothelial systems.
    Rohovsky MW; Newberne JW; Gibson JP
    Toxicol Appl Pharmacol; 1970 Sep; 17(2):556-8. PubMed ID: 4990538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of severe epithelial dysplasia of esophagus. I. Therapeutic effects of Antitumor B III, Antitumor B and tilorone (author's transl)].
    Cai HY; Shu YJ; Wang GQ; Wu AR; Lin PZ; Liu SF; Li MX
    Zhonghua Zhong Liu Za Zhi; 1980; 2(2):92-5. PubMed ID: 7418605
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2,7-bis(2-diethylamino)ethoxy)fluoren-9-one dihydrochloride (Tilorone) upon cell-mediated immunity in mice.
    Friedlaender GE; Mosher MB; Mitchell MS
    Cancer Res; 1974 Feb; 34(2):304-7. PubMed ID: 4544018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.